Upload Avatar (500 x 500)
Chuandong Cheng
Mayo Clinic College of Medicine
University of Science and Technology of China
Anhui
Language: Chinese, English
Neurosurgery
Glioma
Molecular Pathology
Multimodal Imaging
Glycolipid Metabolism
Immune Regulation
Metabolic Microenvironment
Machine Learning
Diagnosis
Treatment
Areas of Focus
- Neurosurgery
- Construction of a stratified diagnosis and treatment system for glioma based on molecular pathology and multimodal imaging characteristics
- Regulation mechanism of glioma glycolipid metabolism on tumor and immune cell functions
- New strategies for glioma treatment based on the regulation of immune and metabolic microenvironment
- Application of multimodal imaging analysis of glioma based on machine learning
Work Experience
- 2006/07–2013/11 - Anhui Provincial Hospital - Neurosurgeon
- 2013/12–2018/11 - Anhui Provincial Hospital - Attending Neurosurgeon
- 2018/12–Present - First Affiliated Hospital of University of Science and Technology of China - Associate Chief Neurosurgeon
- 2023/10–Present - University of Science and Technology of China, School of Life Sciences and Medicine - Postdoctoral Researcher
Academic Background & Achievements
- 2001/09–2006/07 Bachelor in Clinical Medicine: Anhui Medical University
- 2010/09–2013/07 Master in Surgery: Anhui Medical University, Supervisor: Chaoshi Niu
- 2016/09–2020/11 Doctorate in Biology: University of Science and Technology of China, Supervisor: Kai Zhong
- Hosted 3 hospital 'Three New' projects
- Received 2 provincial awards
- Received 1 medical new technology award
Publications
- GTF2E2 downregulated by miR-340-5p inhibits the malignant progression of glioblastoma, Xiaolong Qiao, Yinan Chen, Zixuan Wang, Nan Peng, Wanxiang Niu, Shiqiang Hou, Jiaying Wu, Ying Ji, Chaoshi Niu, Chuandong Cheng, 2023
- Single-cell landscape of primary central nervous system diffuse large B-cell lymphoma, Nianping Liu, Chen Jiang, Xinfeng Yao, Minghao Fang, Xiaolong Qiao, Lin Zhu, Zongcheng Yang, Xuyuan Gao, Ying Ji, Chaoshi Niu, Chuandong Cheng, Kun Qu, Jun Lin, 2023
- SREBP2/Rab11s/GLUT1/6 network regulates proliferation and migration of glioblastoma, Chuandong Cheng, Junhong Tu, Zengchun Hu, Yinan Chen, Yue Wang, Ting Zhang, Caihua Zhang, Cong Li, Yang Wang, Chaoshi Niu, 2022
- Gliosarcoma: The Distinct Genomic Alterations Identified by Comprehensive Analysis of Copy Number Variations, Chuandong Cheng, Chen C, Wang L, Dong YF, Yang Y, Chen YN, Niu WX, Wang WC, Liu QS, Niu CS, 2022
- Synergistic Effect of Statins and Abiraterone Acetate on the Growth Inhibition of Neuroblastoma via Targeting Androgen Receptor, Hu Z, Chuandong Cheng, Wang Y, Chen T, Tu J, Niu C, Xing R, Wang Y, Xu Y, 2021
- LncRNA ANCR promotes glioma cells invasion, migration, proliferation and inhibits apoptosis via interacting with EZH2 and repressing PTEN expression, Chuandong Cheng, Dong Y, Ru X, Xia Y, Ji Y, 2021
- Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway, Cheng Chen, Chuandong Cheng, Hong Wu, Chen C, Cheng CD, Wu H, Wang ZW, Wang L, Jiang ZR, Wang AL, Hu C, Dong YF, Niu WX, Qi S, Qi ZP, Liu J, Wang WC, Niu CS, Liu QS, 2021
- EZH2 is a potential prognostic predictor of glioma, Chen YN, Hou SQ, Jiang R, Sun JL, Chuandong Cheng, Qian ZR, 2021
Awards
- Science and Technology Progress Award (2013): Third Prize by Anhui Provincial Government
- Anhui Province Glioma Case Competition (2018): First Prize by Anhui Medical Association
- National Glioma Surgery Competition (2022): Third Prize by Chinese Medical Association
